|
Completed
|
NCT04202757 -
Intravenous Plasma Treatment for Parkinson's Disease
|
Early Phase 1 |
|
Not yet recruiting
|
NCT05103618 -
Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA
|
Phase 2 |
|
Completed
|
NCT03700684 -
Voice Treatment for Parkinson's Disease
|
N/A |
|
Completed
|
NCT05027620 -
Feasibility of Motor-cognitive Home Training for Parkinson's Disease Using eHealth Technology
|
N/A |
|
Completed
|
NCT03652363 -
GDNF in ideopathicParkinsons Disease
|
Phase 2 |
|
Recruiting
|
NCT02960464 -
tDCS for Treatment of Depression in Parkinson's Disease
|
N/A |
|
Completed
|
NCT05699161 -
Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson
|
Phase 1/Phase 2 |
|
Completed
|
NCT03944785 -
Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)
|
|
|
Completed
|
NCT01227265 -
Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)
|
Phase 3 |
|
Terminated
|
NCT01215227 -
An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)
|
Phase 3 |
|
Withdrawn
|
NCT05832775 -
Study to Assess the Safety of MRx0029 or MRx0005 Compared to Placebo, in People With Parkinson's
|
Phase 1 |
|
Active, not recruiting
|
NCT02780895 -
Parkinsonian Brain Repair Using Human Stem Cells
|
Phase 1 |
|
Recruiting
|
NCT01860794 -
Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease
|
Phase 1/Phase 2 |
|
Terminated
|
NCT02393027 -
Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999
|
Early Phase 1 |
|
Completed
|
NCT02373072 -
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease
|
Phase 1 |
|
Completed
|
NCT02445651 -
Physiological Effects of Nutritional Support in Patients With Parkinson's Disease
|
N/A |
|
Completed
|
NCT00437125 -
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
|
Phase 4 |
|
Completed
|
NCT02723396 -
Sleep, Awake & Move - Part I
|
|
|
Completed
|
NCT00599339 -
Transdermal Rotigotine User Surveillance Study
|
|
|
Completed
|
NCT00160576 -
Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias
|
Phase 2 |